Find your next M&A target

The Korean company has developed the bioelectronic nose sensor technology based on human olfactory receptor and uses it to manufacture medical devices for early cancer diagnosis. The company's bioelectronic nose sensor is a super sensitive sensor, which can detect cancer earlier than any sensor or instrument. The examinee only needs to exhale on the inspection machine for about 1 minute to complete the inspection. There is no discomfort during the inspection. In addition, due to the mass production technology of sensors, the manufacturing cost of sensors is low and so the inspection cost is very low. The company has completed the development of a special bioelectronic nose sensor for early diagnosis of gastric cancer in 2019 and has completed three olfactory receptor sensors, all of which have been registered for patent. The expiratory examination instrument products will be licenced for sale through clinical trials in a short period. The company seeks USD 5 million for equity financing.